Federal contract award

75F40120F19001

TASK ORDER 1 FOR ACCESS TO OUTPATIENT PRESCRIPTION AND PATIENT LEVEL DRUG UTILIZATION DATA

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeFDA OFFICE OF ACQ GRANT SVCS
NAICS541519 — Other Computer Related Services
PSCB529 — Scientific Data Studies
Parent award / vehicle75F40120D00012
Set-asideNot reported
Pricing typeFIRM FIXED PRICE
Obligations$21.3M
Current contract value$21.3M
Potential contract value / ceiling$21.3M
Start dateMay 22, 2020
Current end dateAug 21, 2025
Potential end dateAug 21, 2025
Latest award activityJan 21, 2026
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 8 of 8 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Jan 21, 2026P00007$-0TASK ORDER 1 FOR ACCESS TO OUTPATIENT PRESCRIPTION AND PATIENT LEVEL DRUG UTILIZATION DATA
May 1, 2025P00006$1.0MMOD P00006 EXTENSION THE POP - OPTION PERIOD 4 - TASK ORDER 1 FOR ACCESS TO OUTPATIENT PRESCRIPTION AND PATIENT LEVEL DRUG UTILIZATION DATA
May 3, 2024P00005$4.2MTASK ORDER 1 FOR ACCESS TO OUTPATIENT PRESCRIPTION AND PATIENT LEVEL DRUG UTILIZATION DATA
May 16, 2023P00004$4.1MTASK ORDER 1 FOR ACCESS TO OUTPATIENT PRESCRIPTION AND PATIENT LEVEL DRUG UTILIZATION DATA
Nov 23, 2022P00003$0TASK ORDER 1 FOR ACCESS TO OUTPATIENT PRESCRIPTION AND PATIENT LEVEL DRUG UTILIZATION DATA
May 19, 2022P00002$4.0MTASK ORDER 1 FOR ACCESS TO OUTPATIENT PRESCRIPTION AND PATIENT LEVEL DRUG UTILIZATION DATA
Mar 22, 2021P00001$4.0MTASK ORDER 1 FOR ACCESS TO OUTPATIENT PRESCRIPTION AND PATIENT LEVEL DRUG UTILIZATION DATA
May 22, 20200$3.9MTASK ORDER 1 FOR ACCESS TO OUTPATIENT PRESCRIPTION AND PATIENT LEVEL DRUG UTILIZATION DATA

Research next steps

  1. Confirm the ordering vehicle and your eligibility or a qualified teaming route.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.